Unlearn AI

Unlearn.AI develops artificial intelligence (AI) technology to create digital twins of clinical trial participants. These digital twins are virtual models that predict patient health outcomes over time. The company uses this technology to streamline and accelerate clinical trials, reducing the number of participants needed in control groups and potentially speeding up the drug development process.